$TBRG

Harse David sold (to issuer) $443K of TBRG

Harse David (General Manager Patient Care) sold (to issuer) 21,091 shares of TruBridge, Inc. (TBRG) at $26.25 ($0.44M total) across 2 trades on 2026-07-09.

Original reporting
SEC EDGAR · Harse David
Published Jul 10, 2026, 2:41 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 10, 2026, 2:42 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$TBRG
Neutral
high confidence
Mentioned
$TBRG
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TBRGNeutralLow
01

Why it matters

The newest fact is the disclosed sale size, price ($26.25 for one tranche), and post-transaction holdings (0 shares). No new business developments are provided.

02

Market read

Traders may monitor insider activity for sentiment, but this filing alone does not provide a fundamental catalyst.

03

What to watch

The filing notes no 10b5-1 plan and includes one trade with undisclosed price, so interpretation of intent is limited without full Form 4 details.

Relevance 4/10Novelty 3/10Timing: Filed on 2026-07-10 for a 2026-07-09 insider sale to the issuer.

Background

The article is an SEC Form 4 insider transaction disclosure for TruBridge, Inc. (TBRG).

Company-level read

Ticker impact

$TBRGNeutralHigh confidence
Context

TruBridge insider Harse David sold 21,091 shares to the issuer at $26.25/share, leaving him with 0 shares after the transaction.

Expected impact

Likely minimal near-term impact; any effect would be sentiment-only and typically fades quickly.

Evidence & confidence

The filing is a disclosed insider transaction (sale to issuer) with no accompanying guidance, contract, or fundamental change described in the text.

Market effects

No sector read-through; this is company-specific insider transaction data only.

None indicated.

None indicated.

Counterpoint

A sale to the issuer can be administrative (for example, buyback participation or plan mechanics) and may not reflect bearish expectations.

Key entities

  • TruBridge, Inc.

    Company subject of the Form 4 insider transaction disclosure.

  • Harse David

    General Manager Patient Care who sold shares to the issuer.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles